Merck Immunotherapy Drug Shines In Lung Cancer Study – NPR
NBCNews.com |
Merck Immunotherapy Drug Shines In Lung Cancer Study
NPR There's encouraging news for cancer treatments that stimulate the immune system to attack cancer cells. A widely used immunotherapy drug appears to be useful in a greater number of patients with lung cancer. The drug called Keytruda, or pembrolizumab … Immunotherapy transforms lung cancer, the biggest cancer killer Immunotherapy scores big win against lung cancer in study Treatment combo nearly doubles survival time in lung cancer patients, study finds |
